Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 974 of 6351
-
Can a gene test spare breast cancer patients from extra radiation?
Disease control Recruiting nowThe effect of internal mammary irradiation (IMI) added to whole-breast or thoracic-wall irradiation plus supraclavicular (SVC) irradiation after surgery on survival among women with early-stage intermediate risk (N1) breast cancer remains debated. The present study aimed to ident…
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New hope for advanced stomach cancer: drug combo targets patients who failed first-line therapy
Disease control Recruiting nowThis study was an open, single center, prospective cohort study design. Subjects with advanced gastric cancer who had received first-line chemotherapy (cohort 1) and systematic chemotherapy combined with immunotherapy (cohort 2) were included in this study. 20 cases were included…
Phase 2 • Sponsor: Shandong Tumor Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Choosing dialysis or transplant: does a shared approach lead to better decisions?
Knowledge-focused CompletedShared decision making (SDM) is an approach where clinicians and patients make decisions together using the best available evidence. An understanding of the patient's treatment goals, the advantages and disadvantages of treatment options, and the likelihood of achieving the outco…
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
BREAST CANCER TRIAL TESTS IF LESS AXILLARY TREATMENT IS SAFE AFTER CHEMO
Disease control Recruiting nowThe aim of this study is to assess whether, omitting further axillary treatment (ALND and ART) for patients with early stage breast cancer and axillary nodal metastases on needle biopsy, who after NACT have no residual cancer in the lymph nodes on sentinel node biopsy, is non-inf…
Sponsor: University Hospitals of Derby and Burton NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Can a heart drug save lives in septic shock? new trial aims to find out.
Disease control CompletedSeptic shock is a major health problem, with several million cases annually worldwide and a mortality approaching 45%. Tachycardia is associated with excess mortality during septic shock. This pejorative effect could be related to the increase in cardiac metabolic demand, impaire…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Targeted drug before surgery shows promise for RET-Altered thyroid cancer
Disease control OngoingThis phase II trial studies the effect of selpercatinib given before surgery in treating patients with thyroid cancer whose tumors have RET alterations (changes in the genetic material \[deoxyribonucleic acid (DNA)\]). Selpercatinib may stop the growth of tumor cells by blocking …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Experimental drug shows promise for rare amyloidosis
Disease control CompletedThis is an open-label, multicenter, Phase 2 study in subjects with previously treated patients with light chain (AL) amyloidosis in need for therapy. Approximately 35 subjects will receive therapy with belantamab mafodotin. Subject participation will include a Screening Phase, a…
Phase 2 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New hope for breast cancer patients when first treatment fails
Disease control Recruiting nowThe study will investigate if CDK4/6 inhibitor holiday will reset the cell cycle process to respond to the combination of fulvestrant and abemaciclib, and this approach may represent an effective therapeutic strategy to manage such patients.
Phase 2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
What's the right dose? a trial seeks the sweet spot for labor epidurals
Symptom relief CompletedTo estimate the dose of bupivacaine required to achieve initial effective comfort in 90% of patients (ED90) via the epidural (DPE or EPL) technique in women undergoing labor.
Phase 4 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Can a home defibrillator save lives? a real-world test begins.
Disease control Recruiting nowA Prospective study on the performance and safety of the HeartStart OnSite (Model M5066A) \& HeartStart Home (Model M5068A) Defibrillator device data.
Sponsor: Heartstream US LLC • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Experimental cell therapy takes on Hard-to-Treat myeloma
Disease control CompletedThe purpose of this study is to evaluate the safety and preliminary efficacy of CC-95266 in participants with relapsed and/or refractory multiple myeloma (R/R MM).
Phase 1 • Sponsor: Juno Therapeutics, a Subsidiary of Celgene • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New drug targets Hard-to-Treat cancers with KRAS mutation
Disease control OngoingThis is a phase Ib/II open label study. The escalation part will characterize the safety and tolerability of JDQ443 single agent and JDQ443 in combination with the other study treatments (TNO155 and tislelizumab) in advanced solid tumor patients. After the determination of the ma…
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Sanofi's new COVID vaccine shows promise in large trial
Vaccine CompletedThe primary objectives of the study are: To assess the safety profile of the study vaccines in each study intervention group. To assess the neutralizing antibody profile after primary series vaccination in SARS-CoV-2-naïve adults. To demonstrate that a booster dose of monovale…
Phase 2/3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 26, 2026 18:35 UTC
-
New drug cocktail aims to shrink lymphoma tumors without chemo
Disease control OngoingThis phase II trial studies how well obinutuzumab, ibrutinib, and venetoclax work in treating patients with previously untreated stage II-IV follicular lymphoma. Immunotherapy with obinutuzumab may induce changes in body's immune system and may interfere with the ability of tumor…
Phase 2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Heart pump could outperform drugs in advanced heart failure
Disease control Recruiting nowHeart failure is a severe disease affecting approximately 1-2% of the adult population in developed countries and around 26 million people worldwide. Up to 10% of these patients are in advanced stage heart failure, which is defined by a significant morbimortality and considerable…
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could a common steroid improve success after vasectomy reversal?
Disease control Completed1. Determine impact of prednisone on semen parameters post vasectomy reversal (evaluated both using prednisone as a combined cohort as well as via 3 separate protocols). 2. Determine impact of prednisone on pregnancy rates post vasectomy reversal (evaluated both using prednisone …
Phase 4 • Sponsor: Charitable Union for the Research and Education of Peyronie's Disease • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New cell therapy takes on advanced kidney cancer
Disease control OngoingThis is a Phase 1 dose escalation study using a 3+3 study design, followed by a phase 1b expansion study. The purpose of the TRAVERSE study is to assess the safety, efficacy, and cell kinetics of ALLO-316 in adults with advanced or metastatic clear cell renal cell carcinoma after…
Phase 1 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could chemo before surgery boost gallbladder cancer survival?
Disease control OngoingThis phase II/III trial compares the effect of adding chemotherapy before and after surgery versus after surgery alone (usual treatment) in treating patients with stage II-III gallbladder cancer. Chemotherapy drugs, such as gemcitabine and cisplatin, work in different ways to sto…
Phase 2/3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug combo shows promise for rare kidney cancer
Disease control CompletedThis study is being performed as a single-arm open-label study in order to rapidly provide information on the potential benefits of the combination of pembrolizumab and lenvatinib in participants with previously untreated advanced/metastatic non-clear cell renal cell carcinoma.
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Promising drug combo slows advanced prostate cancer in major trial
Disease control CompletedThe purpose of the study is to assess the efficacy and safety of darolutamide in combination with standard androgen deprivation therapy (ADT) in patients with metastatic hormone sensitive prostate cancer.
Phase 3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC